Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

In the News
Greg Scott presents industry update during JPMorgan
>> View video…

>> More News...

Now on Twitter!
 

Twitter ID: ChinaBio

Novozymes Breaks Ground on New China Manufacturing Facility

publication date: Apr 28, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Novozymes, a Danish company that provides enzymes for industrial and consumer use, and also manufactures recombinant biopharma products and APIs, will spend $35-$50 million to build a new facility at its existing site in Tianjin, China. The new factory will produce Bacillus-based Hyaluronic Acid (bHA), which is used in medical devices, topical eye care treatments and drug delivery. More details..

Stock Symbol: (NASDAQ OMX Copenhagen A/S (NZYM B))




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio® Events
April 14, 2010
Guangzhou, China

SEED Final Competion and Award Ceremony
April 23, 2010
Shanghai, China
Suzhou, China
June 23-24, 2010
 
Partner Events

China 2010 Pharmaceutical R&D Summit
Shanghai, China
April 5-8, 2010

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners